Targeting self-antigens through allogeneic TCR gene transfer

Area of Science:

• Immunology
• Cancer immunotherapy
• Gene therapy

Background:

• Adoptive transfer of T-cell receptor (TCR) genes is a proposed immunotherapy strategy.
• Existing research shows TCR-modified T cells can target foreign antigens.
• The efficacy of targeting tumor-associated self-antigens using this method remains unexplored.

Purpose of the Study:

• To investigate the feasibility of TCR gene transfer for inducing self-antigen-specific T-cell responses.
• To assess the potential of TCR gene therapy in partially MHC-mismatched hosts.
• To evaluate the induction of T-cell responsiveness against tumor-associated self-antigens.

Main Methods:

• T-cell receptor gene transfer into T cells.
• Assessment of T-cell reactivity to self-antigens.
• Adoptive transfer studies in partially MHC-mismatched models.
• Evaluation of graft versus host disease.

Main Results:

• TCR gene transfer successfully induced defined self-antigen-specific T-cell responses, even with a nonreactive endogenous repertoire.
• Adoptive transfer of TCR genes generated strong antigen-specific T-cell responsiveness in partially MHC-mismatched hosts.
• No detectable graft versus host disease was observed in the treated hosts.

Conclusions:

• TCR gene transfer is a feasible method to induce self-antigen-specific T-cell immunity.
• This approach can overcome endogenous T-cell nonreactivity and is safe in partially mismatched settings.
• The findings support the clinical testing of "off the shelf" TCR gene therapies for targeting tumor-associated self-antigens.